Glass.Mapper.Sc.Fields.Image
Please note our Product Finder does not contain our complete product portfolio. Should you wish for further information on a specific product, please contact us.
Contact customer care
Roquette Wins "Biopharma Innovation of the Year" Award at Korea Biopharma Excellence Awards 2024

Roquette is proud to announce that we have been honored with the "Biopharma Innovation of the Year" award for 2024 at Biologics Manufacturing Korea and Vaccine World East Asia Congress 2024. This prestigious accolade recognizes our leading-edge work and our commitment to advancing pharmaceutical innovation with our KLEPTOSE® Biopharma hydroxypropyl beta-cyclodextrin solution. 

A Landmark Achievement 

This award is a significant achievement for Roquette, reflecting our dedication to innovation and the impact of our solutions on the biopharma industry. Vinod Tuliani, VP & Head of Global Pharmaceutical Sciences, commented on the award: “Winning this award is a tremendous honor for Roquette. It highlights our commitment to pushing the boundaries of pharmaceutical innovation and showcases the success of our KLEPTOSE® Biopharma solution. This recognition underscores the expertise of our team and inspires us to continue advancing our solutions to meet the evolving needs of the industry.” 

KLEPTOSE® Biopharma: A Game-Changer in the Industry 

KLEPTOSE® Biopharma has been instrumental in overcoming critical challenges faced by biopharmaceutical companies. Its advanced formulation enhances protein recovery, reduces particle formation, and stabilizes antibodies during formulation. Notably, KLEPTOSE® Biopharma offers superior stability compared to other products, effectively addresses subvisible particle formation, and provides viscosity reduction for highly concentrated monoclonal antibodies (mAbs). Its effectiveness in reducing aggregation in antibody-drug conjugates (ADCs) and its wide application in vaccine development make it a vital tool for the biopharma sector. 

Future Priorities 

This recognition reaffirms our commitment to innovation and excellence. Our future priorities include: 

  • Driving Innovation: Continuously developing advanced pharmaceutical excipients and drug delivery systems.
  • Advancing Sustainability: Committing to sustainable practices and reducing our environmental footprint.
  • Strengthening Collaborations: Expanding partnerships with biopharma companies and research institutions.
  • Expanding Global Reach: Enhancing our presence in emerging markets to serve a diverse global client base.

We extend our sincere thanks to the biopharma community for their support and recognition. This award motivates us to continue pushing the boundaries of pharmaceutical innovation and to collaborate on achieving new milestones. 

For more information about our award-winning solutions, please visit our Pharma Virtual Lab by Roquette.

1 / 5